Review your dietary intake first
This fundamental difference explains why GLP-1 drugs like semaglutide have emerged as powerful tools for weight management, while sitagliptin offers more modest metabolic effects
Once key patents expire, Indian companies can launch generics or biosimilars (biologic medicines that are highly similar to the original, with no meaningful difference in safety or effect), provided the Central Drugs Standard Control Organisation (CDSCO) approves them after reviewing quality, safety, and efficacy
We want to treat obesity as a whole and for long term
Next, Bromelain, a valuable component of various weight loss and diet regimens, contributes to your overall health
Retrieved November 1, 2023, from Shah, A